Amicasa Hospice Home Care 3482 Flat Shoals Road, Decatur, GA, 30034 | |
(404) 537-1960 |
News Archive
Point-of-care ultrasound is helping to improve the quality of life for metastatic breast cancer patients in the West Midlands thanks to the fundraising efforts of Breast Friends Solihull and the University Hospitals Birmingham Charity.
The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to ravage across the globe, with the number of confirmed cases topping 35.65 million.
When it comes to pain, the two competing schools of thought are that it's either "all in your head" or "all in your body". A new study led by University of Oxford researchers indicates that, instead, pain is an amalgam of the two.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
› Verified 3 days ago
Name | Amicasa Hospice Home Care |
---|---|
Location | 3482 Flat Shoals Road, Decatur, Georgia |
Hospice ID | 111707 |
Category | Freestanding Hospice |
Ownership Type | Other |
Profit Type | OTHER |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 370 |
News Archive
Point-of-care ultrasound is helping to improve the quality of life for metastatic breast cancer patients in the West Midlands thanks to the fundraising efforts of Breast Friends Solihull and the University Hospitals Birmingham Charity.
The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to ravage across the globe, with the number of confirmed cases topping 35.65 million.
When it comes to pain, the two competing schools of thought are that it's either "all in your head" or "all in your body". A new study led by University of Oxford researchers indicates that, instead, pain is an amalgam of the two.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
› Verified 3 days ago
NPI Number | 1396065777 |
Organization Name | Amicasa Home Care Corporation |
Address | 157 Burke Street Stockbridge, Georgia, 30281 |
Phone Number | (404)537-1960 |
News Archive
Point-of-care ultrasound is helping to improve the quality of life for metastatic breast cancer patients in the West Midlands thanks to the fundraising efforts of Breast Friends Solihull and the University Hospitals Birmingham Charity.
The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to ravage across the globe, with the number of confirmed cases topping 35.65 million.
When it comes to pain, the two competing schools of thought are that it's either "all in your head" or "all in your body". A new study led by University of Oxford researchers indicates that, instead, pain is an amalgam of the two.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
› Verified 3 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 100.0 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 97.1 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Point-of-care ultrasound is helping to improve the quality of life for metastatic breast cancer patients in the West Midlands thanks to the fundraising efforts of Breast Friends Solihull and the University Hospitals Birmingham Charity.
The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to ravage across the globe, with the number of confirmed cases topping 35.65 million.
When it comes to pain, the two competing schools of thought are that it's either "all in your head" or "all in your body". A new study led by University of Oxford researchers indicates that, instead, pain is an amalgam of the two.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
› Verified 3 days ago
Home Health Aides | 8 |
Counselors | 1 |
Licensed Practical or Vocational Nurses | 1 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 4 |
Total Employees | 16 |
---|
News Archive
Point-of-care ultrasound is helping to improve the quality of life for metastatic breast cancer patients in the West Midlands thanks to the fundraising efforts of Breast Friends Solihull and the University Hospitals Birmingham Charity.
The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to ravage across the globe, with the number of confirmed cases topping 35.65 million.
When it comes to pain, the two competing schools of thought are that it's either "all in your head" or "all in your body". A new study led by University of Oxford researchers indicates that, instead, pain is an amalgam of the two.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
› Verified 3 days ago
Dynamic Hospice Location: 2799 Lawrenceville Hwy, Suite 106, Decatur, Georgia, 30033 Phone: (404) 537-1960 |
Amicasa Hospice Home Care Location: 3482 Flat Shoals Road, Decatur, Georgia, 30034 Phone: (404) 537-1960 |